drugset / Trial / NCT00466986
Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if the combination of Abraxane and Carboplatin together will improve the chances of controlling recurrent ovarian/fallopian tube/peritoneal cancer.
Timeline
- Start
- 2005-11
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abraxane | Small molecule | — | — |
| Background | Carboplatin | Small molecule | — | — |